1h Free Analyst Time
The hyaluronic acid market is forecasted to grow by USD 4.46 billion during 2023-2028, accelerating at a CAGR of 8.09% during the forecast period. The report on the hyaluronic acid market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by need for safe and stable drugs that require minimal monitoring, rising demand for non-surgical aesthetic procedures, and advancements in delivery systems of hyaluronic acid molecules in cosmetics.
The hyaluronic acid market is segmented as below:
By Application
- Dermal fillers
- Osteoarthritis
- Ophthalmic
- Vesicoureteral reflux
By End-user
- Pharmaceutical industry
- Cosmetic industry
By Geographical Landscape
- North America
- APAC
- Europe
- Middle East and Africa
- South America
The report on the hyaluronic acid market covers the following areas:
- Hyaluronic acid market sizing
- Hyaluronic acid market forecast
- Hyaluronic acid market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global hyaluronic acid market: AbbVie Inc., Abdi Ibrahim Ilac Sanayi ve Tic A.S., Anika Therapeutics Inc., Bausch Health Companies Inc., Bio plus Co. Ltd., BioScience GmbH Cosmetics Trading LLC, Bioxis Pharmaceutical, Bloomage Biotech Co. Ltd., Ferring BV, Fidia Farmaceutici Spa, Galderma SA, Huadong Medicine Co. Ltd., Laboratoires VIVACY, LG Chem Ltd., Merz Pharma GmbH and Co KGaA, Sanofi SA, SEIKAGAKU CORP., Smith and Nephew plc, Syrhatech, Teva Pharmaceutical Industries Ltd., and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing acquisitions and joint ventures by market vendors."
According to the report, one of the major drivers for this market is the need for safe and stable drugs that require minimal monitoring.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Abdi Ibrahim Ilac Sanayi ve Tic A.S.
- Anika Therapeutics Inc.
- Bausch Health Companies Inc.
- Bio plus Co. Ltd.
- BioScience GmbH Cosmetics Trading LLC
- Bioxis Pharmaceutical
- Bloomage Biotech Co. Ltd.
- Ferring BV
- Fidia Farmaceutici Spa
- Galderma SA
- Huadong Medicine Co. Ltd.
- Laboratoires VIVACY
- LG Chem Ltd.
- Merz Pharma GmbH and Co KGaA
- Sanofi SA
- SEIKAGAKU CORP.
- Smith and Nephew plc
- Syrhatech
- Teva Pharmaceutical Industries Ltd.
- Zimmer Biomet Holdings Inc.
